Hartford Healthcare R6 (HGHVX)
| Fund Assets | 769.28M |
| Expense Ratio | 0.92% |
| Min. Investment | $0.00 |
| Turnover | 40.00% |
| Dividend (ttm) | 2.11 |
| Dividend Yield | 4.69% |
| Dividend Growth | n/a |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 27, 2024 |
| Previous Close | 45.64 |
| YTD Return | 3.59% |
| 1-Year Return | -7.76% |
| 5-Year Return | 11.18% |
| 52-Week Low | 39.10 |
| 52-Week High | 51.66 |
| Beta (5Y) | n/a |
| Holdings | 81 |
| Inception Date | Feb 28, 2019 |
About HGHVX
The Hartford Healthcare Fund Class R6 is an actively managed mutual fund dedicated to investments in the global healthcare sector. Its primary objective is to achieve long-term capital appreciation by allocating at least 80% of its assets to equity securities of healthcare-related companies across the world. The fund targets a broad spectrum of businesses within the sector, including those involved in pharmaceuticals, biotechnology, medical devices, medical services, and healthcare technology. Managed by Hartford Mutual Funds with sub-advisory from Wellington Management Company, the fund leverages in-depth research to identify firms poised to benefit from demographic changes, globalization, and innovation within healthcare. With a diverse portfolio typically consisting of around 100 holdings, the fund invests mainly in large-capitalization companies, though it maintains exposure across various market caps. The Class R6 share structure is tailored for institutional investors, offering a competitive expense ratio and no minimum investment requirement. By focusing globally and embracing healthcare’s dynamic landscape, the Hartford Healthcare Fund Class R6 plays a specialized role in investor portfolios seeking to capitalize on long-term trends in health and life sciences, as measured against benchmarks like the S&P Composite 1500 Health Care Index.
Performance
HGHVX had a total return of -7.76% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.38%.
Top 10 Holdings
47.73% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.37% |
| UnitedHealth Group Incorporated | UNH | 5.67% |
| Boston Scientific Corporation | BSX | 4.62% |
| Johnson & Johnson | JNJ | 4.47% |
| Merck & Co., Inc. | MRK | 4.12% |
| AbbVie Inc. | ABBV | 3.84% |
| Intuitive Surgical, Inc. | ISRG | 3.57% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.20% |
| Danaher Corporation | DHR | 3.05% |
| Cencora, Inc. | COR | 2.83% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2024 | $0.21018 | Dec 30, 2024 |
| Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
| Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
| Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
| Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
| Dec 10, 2019 | $2.36232 | Dec 11, 2019 |